INVIVO THERAPEUTICS HOLDINGS CORP. Annual Nonoperating Income (Expense) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
  • Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $131K, a 191% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $529K, a 690% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $160K, a 3100% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2021 was $5K, a 78.3% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2020 was $23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $160K +$155K +3100% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $5K -$18K -78.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $23K +$356K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 -$333K +$10.3M +96.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$10.7M -$8.5M -395% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 -$2.15M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2011 -$26.1M -$21.6M -478% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-15
2010 -$4.51M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.